Aruna Kamineni, PhD, MPH

“I'm working on reducing cancer through better screening. I collaborate with researchers nationwide on studies that will make screening more effective, patient-friendly, and personalized.”

Aruna Kamineni, PhD, MPH

Assistant Investigator, Kaiser Permanente Washington Health Research Institute

Aruna.S.Kamineni@kp.org
206-287-2922

Curriculum vitae (CV)

Biography

Aruna Kamineni, PhD, MPH, came to Kaiser Permanente Washington Health Research Institute in 2009 with a wealth of experience in chronic disease epidemiology. Dr. Kamineni has expertise in using case-control methods to evaluate screening efficacy, and her research focuses on addressing evidence gaps for clinical guidelines, particularly for cervical and colorectal cancer prevention. A substantial portion of her work has focused on developing infrastructure and methods for research using electronic clinical and administrative health care data.

Since 2011, Dr. Kamineni has participated in the National Cancer Institute’s Population-based Research to Optimize the Screening Process (PROSPR) consortium to evaluate and improve cancer screening in U.S. community settings. As a principal investigator for multisite cervical and colorectal cancer PROSPR Research Centers, Dr. Kamineni is leading and collaborating on work to determine how to optimally use screening tests and consider how to tailor screening for population subgroups.

Dr. Kamineni’s research goals include studying the impact of human papillomavirus (HPV) DNA testing and HPV vaccination on cervical cancer and screening programs. Multidisciplinary collaboration is a valued and important driver of Dr. Kamineni’s research and she embraces a team science approach to optimizing cancer prevention.

Research interests and experience

Cancer

Cervical cancer; colorectal cancer; screening; disparities
Methods

Electronic clinical and administrative data infrastructure development for research; case-control studies; team science

Recent publications

Pocobelli G, Lykken J, Haas JS, Tiro J, Doria-Rose VP, Hyun N, Silver MI, Kamineni A, Chubak J Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systems 2025 Nov;36(11):1549-1561 doi:10.1007/s10552-025-02039-7. doi: 10.1007/s10552-025-02039-7. Epub 2025-08-06. PubMed

Sheridan L, Pocobelli G, Anderson M, Li CI, Kruse GR, Tiro JA, Kamineni A Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019 2025 Mar;36(3):275-284. doi: 10.1007/s10552-024-01937-6. Epub 2024-11-13. PubMed

Levin TR, Jensen CD, Udaltsova N, Burnett-Hartman AA, Kamineni A, Chao CR, Schottinger JE, Ghai NR, Pocobelli G, White LL, Oliver M, Chowdhry H, Hixon BP, Badalov JM, Goldberg SR, Bradford SC, Quesenberry CP, Lee JK Colorectal Cancer Screening Completion and Yield in Patients Aged 45 to 50 Years : An Observational Study 2024 Dec;177(12):1621-1629. doi: 10.7326/M24-0743. Epub 2024-10-22. PubMed

McDowell A, Rieu-Werden ML, Atlas SJ, Fields CD, Goldstein RH, Gundersen GD, Haas JS, Higashi RT, Pruitt SL, Silver MI, Tiro JA, Kamineni A Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix 2024 Oct;11(7):563-569. doi: 10.1089/lgbt.2023.0067. Epub 2024-04-22. PubMed

Lee JK, Jensen CD, Udaltsova N, Zheng Y, Levin TR, Chubak J, Kamineni A, Halm EA, Skinner CS, Schottinger JE, Ghai NR, Burnett-Hartman A, Issaka R, Corley DA Predicting Risk of Colorectal Cancer After Adenoma Removal in a Large, Community-based Setting 2024 Aug;119(8):1590-1599. doi: 10.14309/ajg.0000000000002721. Epub 2024-02-14. PubMed

Cheng D, Rieu-Werden ML, Lykken JM, Werner CL, Feldman S, Silver MI, Atlas SJ, Tiro JA, Haas JS, Kamineni A Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings 2024 Jul;33(7):912-922. doi: 10.1158/1055-9965.EPI-23-1564. Epub 2024-04-23. PubMed

Lee JK, Roy A, Jensen CD, Chan JT, Zhao WK, Levin TR, Chubak J, Halm EA, Skinner CS, Schottinger JE, Ghai NR, Burnett-Hartman AN, Kamineni A, Udaltsova N, Corley DA Surveillance Colonoscopy Findings in Older Adults With a History of Colorectal Adenomas 2024 Apr;7(4):e244611. doi: 10.1001/jamanetworkopen.2024.4611. Epub 2024-04-01. PubMed

White LL, Burnett-Hartman AN, Ichikawa LE, Goldberg SR, Chubak J, Spencer Feigelson H, Kamineni A SARS-CoV-2 Infection and Related Hospitalization Among Cancer Survivors 2024 Mar;33(3):442-444. doi: 10.1158/1055-9965.EPI-23-1303. Epub 2023-12-21. PubMed

Pocobelli G, Oliver M, Albertson-Junkans L, Gundersen G, Kamineni A Validation of human immunodeficiency virus diagnosis codes among women enrollees of a U.S. health plan 2024 Feb 22;24(1):234. doi: 10.1186/s12913-024-10685-x. Epub 2024-02-22. PubMed

Kamineni A, Chubak J, Tiro JA, Alimena S, Lykken JM, Haas JS, Werner C, Kobrin SC, Feldman S Timing of Colposcopy and Risk of Cervical Cancer 2024 Feb; 79(2): 91-93. doi: 10.1097/OGX.0000000000001248. PubMed